RYZUMVI FDA approval date

The FDA approved RYZUMVI on 25 Sep 2023.

FDA approval date
25 Sep 2023

Drug identity has not yet been verified against registry records

Also recorded as PHENTOLAMINE MESYLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-09-25DayRYZUMVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217064", "applicant_as_listed_by_fda": "FAMYGEN LIFE SCI", "brand_names": ["RYZUMVI"], "active_ingredients": ["PHENTOLAMINE MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230925", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026